Lv11
48 积分 2025-02-19 加入
Rocbrutinib, a Highly Selective Fourth-Generation Covalent and Noncovalent BTK Inhibitor, in R/R Non-GCB DLBCL: Efficacy and Safety from a Phase I Study
8天前
已完结
Red Blood Cell Transfusion
20天前
已完结
Platelet Transfusion
20天前
已完结
Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance Study
1个月前
已完结
Neurological and Psychiatric Adverse Events Associated with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer Patients: Insights from a Pharmacovigilance Study via the FDA Adverse Event Reporting System
1个月前
已完结
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database
1个月前
已完结
Correlations Between SGLT-2 Inhibitors and Acute Renal Failure by Signal Detection Using FAERS: Stratified Analysis for Reporting Country and Concomitant Drugs
1个月前
已完结
Pharmacokinetic and bioequivalence study of new S-1 capsule in Chinese cancer patients
2个月前
已完结
Determination of Tigecycline in Plasma and Bronchoalveolar Lavage Fluid by UPLC–MS/MS and Its Application to a Pharmacokinetic Study in Critically Ill Patients
4个月前
已完结
Extreme variability in linezolid concentrations in the ICU: A case for routine therapeutic drug monitoring
4个月前
已完结